BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4364808)

  • 1. Recovery of hypothalamic-pituitary-adrenal function, growth hormone responsiveness and sleep EEG pattern in a patient following removal of an adrenal cortical adenoma.
    Krieger DT; Gewirtz GP
    J Clin Endocrinol Metab; 1974 Jun; 38(6):1075-82. PubMed ID: 4364808
    [No Abstract]   [Full Text] [Related]  

  • 2. Sleep EEG stages and plasma growth hormone concentration in states of endogenous and exogenous hypercortisolemia or ACTH elevation.
    Krieger DT; Glick SM
    J Clin Endocrinol Metab; 1974 Dec; 39(6):986-1000. PubMed ID: 4372249
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship of sleep and sleep stages to neuroendocrine secretion and biological rhythms in man.
    Weitzman ED; Boyar RM; Kapen S; Hellman L
    Recent Prog Horm Res; 1975; 31():399-446. PubMed ID: 172995
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 7. Glandular end organ deficiency associated with secretion of biologically inactive pituitary peptides.
    Krieger DT
    J Clin Endocrinol Metab; 1974 Jun; 38(6):964-75. PubMed ID: 4364811
    [No Abstract]   [Full Text] [Related]  

  • 8. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
    Crystal RG; Rose LI; Jagger PI; Lauler DP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of amino-glutethimide on adrenal function in man.
    Fishman LM; Liddle GW; Island DP; Fleischer N; Küchel O
    J Clin Endocrinol Metab; 1967 Apr; 27(4):481-90. PubMed ID: 4290077
    [No Abstract]   [Full Text] [Related]  

  • 10. Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.
    Schteingart DE; Tsao HS
    J Clin Endocrinol Metab; 1980 May; 50(5):961-6. PubMed ID: 6246139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenocortical regulation. A contribution to its assessment, development and disorders in infancy and childhood with special reference to plasma cortisol circadian rhythm.
    Zurbrügg RP
    Monogr Paediatr; 1976; 7():1-83. PubMed ID: 177857
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent steroid therapy. Its effect on hypothalamic-pituitary-adrenal function and the response of plasma growth hormone and insulin to stimulation.
    Martin MM; Gaboardi F; Podolsky S; Raiti S; Calcagno PL
    N Engl J Med; 1968 Aug; 279(6):273-8. PubMed ID: 4298259
    [No Abstract]   [Full Text] [Related]  

  • 13. The central nervous system and Cushing's syndrome.
    Krieger DT
    Mt Sinai J Med; 1972; 39(5):416-28. PubMed ID: 4342962
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth hormone and cortisol responsiveness in Cushing's syndrome. Relation to a possible central nervous system etiology.
    Krieger DT; Glick SM
    Am J Med; 1972 Jan; 52(1):25-40. PubMed ID: 5058357
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased melatonin concentration in Cushing's syndrome.
    Soszyński P; Stowińska-Srzednicka J; Kasperlik-Zatuska A; Zgliczyński S
    Horm Metab Res; 1989 Dec; 21(12):673-4. PubMed ID: 2559013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secretion of growth hormone and ACTH in pituitary tumors].
    Materazzi F; Rolla M; Tronchetti F
    Ann Endocrinol (Paris); 1972; 33(4):344-52. PubMed ID: 4351893
    [No Abstract]   [Full Text] [Related]  

  • 17. Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management.
    McLeod MK; Thompson NW; Gross MD; Bondeson AG; Bondeson L
    Am Surg; 1990 Jul; 56(7):398-403. PubMed ID: 2164335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Function studies of the hypothalamus-anterior-pituitary-adrenal cortex system following surgery of cortisol-producing adrenal gland adenoma].
    Bethge H; Winkelmann W; Bayer JM; Kracht J; Hackenberg K
    Dtsch Med Wochenschr; 1972 Aug; 97(31):1143-4. PubMed ID: 4339679
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin.
    Fitzgerald PA; Aron DC; Findling JW; Brooks RM; Wilson CB; Forsham PH; Tyrrell JB
    J Clin Endocrinol Metab; 1982 Feb; 54(2):413-22. PubMed ID: 6274904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polymicroadenomatosis of the adrenal cortex in Cushing's syndrome. 15 cases].
    Bricaire H; Luton JP; Ghozland M; Forest M
    Ann Med Interne (Paris); 1970 Oct; 121(10):755-77. PubMed ID: 4324710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.